CIK 0000907654 · Non-accelerated filer<br>Smaller reporting company
Oruka Therapeutics, Inc.
Sign in to watch- Ticker
- ORKA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 363855489
- Phone
- 650-606-7910
- Business address
- 855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
- Former names
- ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $20,653,308
- in 17 filings, $20.2M under 10b5-1 plans
Net −$20,653,308. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Klein Lawrence Otto −$11.6M Chief Executive Officer sold 12% of stake
- Agarwal Arjun −$2.8M Senior Vice President, Finance sold 68% of stake
- Goncalves Joana −$2.0M Chief Medical Officer sold 41% of stake
- BALL KRISTINE M −$1.9M Director sold 100% of stake
- Quinlan Paul T −$1.7M General Counsel sold 40% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-19 | Fairmount Funds Management LLC Director | Option exercise | +160,000 | 798,614 | ||
| 2024-11-19 | Fairmount Funds Management LLC Director | Option exercise · Series A Non-Voting Convertible Preferred Stock | −160 | 0 | ||
| 2024-09-11 | Fairmount Funds Management LLC Director | Grant or award | +275,000 | $23.00 | $6.3M | 638,614 |
| 2024-09-11 | Fairmount Funds Management LLC Director | Grant or award · Series A Non-Voting Convertible Preferred Stock | +160 | $23,000.00 | $3.7M | 160 |
| 2024-08-29 | Ma-Weaver Jacob See footnote 1 | Other disposition · Stock option (right to buy) | −6,000 | 0 | ||
| 2024-08-29 | Ma-Weaver Jacob See footnote 1 | Other disposition · Stock option (right to buy) | −6,000 | 0 | ||
| 2024-08-29 | Ma-Weaver Jacob See footnote 1 | Other disposition · Stock option (right to buy) | −12,000 | 0 | ||
| 2024-08-16 | JANUS HENDERSON GROUP PLC 10% owner | Purchase | +5,390 | $2.93 | $16K | 2,116,785 |
| 2024-08-16 | JANUS HENDERSON GROUP PLC 10% owner | Purchase | +428 | $2.98 | $1K | 2,117,213 |
| 2024-07-25 | JANUS HENDERSON GROUP PLC 10% owner | Purchase | +30,227 | $3.05 | $92K | 2,111,395 |
| 2024-07-24 | JANUS HENDERSON GROUP PLC 10% owner | Purchase | +165,000 | $3.20 | $528K | 2,056,312 |
| 2024-07-24 | JANUS HENDERSON GROUP PLC 10% owner | Purchase | +17,800 | $3.18 | $57K | 2,074,112 |
| 2024-07-24 | JANUS HENDERSON GROUP PLC 10% owner | Purchase | +7,056 | $3.16 | $22K | 2,081,168 |
| 2024-07-11 | JANUS HENDERSON GROUP PLC 10% owner | Purchase | +94,537 | $3.45 | $326K | 1,891,312 |
| 2024-07-10 | JANUS HENDERSON GROUP PLC 10% owner | Purchase | +33,500 | $3.46 | $116K | 1,774,812 |
| 2024-07-10 | JANUS HENDERSON GROUP PLC 10% owner | Purchase | +21,963 | $3.46 | $76K | 1,796,775 |
| 2024-07-09 | JANUS HENDERSON GROUP PLC 10% owner | Purchase | +16,917 | $3.43 | $58K | 1,741,312 |
| 2024-07-08 | JANUS HENDERSON GROUP PLC 10% owner | Purchase | +29,892 | $3.41 | $102K | 1,706,795 |
| 2024-07-08 | JANUS HENDERSON GROUP PLC 10% owner | Purchase | +17,600 | $3.54 | $62K | 1,724,395 |
| 2024-07-05 | JANUS HENDERSON GROUP PLC 10% owner | Purchase | +23,326 | $3.43 | $80K | 1,671,903 |
Page 15 of 18 · 346 trades